statistiche ricercatore

Continente	#
NA - Nord America	1.062
AS - Asia	943
EU - Europa	655
SA - Sud America	237
Continente sconosciuto - Info sul continente non disponibili	17
AF - Africa	11
OC - Oceania	2
Totale	2.927

Nazione	#
US - Stati Uniti d'America	980
SG - Singapore	341
IT - Italia	244
CN - Cina	223
BR - Brasile	178
RU - Federazione Russa	156
VN - Vietnam	129
BD - Bangladesh	80
GB - Regno Unito	47
HK - Hong Kong	47
CA - Canada	46
DE - Germania	41
FR - Francia	37
FI - Finlandia	30
IN - India	30
SE - Svezia	23
MX - Messico	20
PL - Polonia	20
AR - Argentina	17
ID - Indonesia	17
TR - Turchia	17
EC - Ecuador	14
NL - Olanda	14
IQ - Iraq	10
JP - Giappone	10
AT - Austria	9
CO - Colombia	9
ES - Italia	9
PK - Pakistan	7
PE - Perù	6
IL - Israele	5
PY - Paraguay	5
UA - Ucraina	5
VE - Venezuela	5
CR - Costa Rica	4
JO - Giordania	4
LT - Lituania	4
MY - Malesia	4
UZ - Uzbekistan	4
CH - Svizzera	3
JM - Giamaica	3
BY - Bielorussia	2
CI - Costa d'Avorio	2
CL - Cile	2
DO - Repubblica Dominicana	2
GR - Grecia	2
GT - Guatemala	2
KE - Kenya	2
KZ - Kazakistan	2
MA - Marocco	2
SA - Arabia Saudita	2
AE - Emirati Arabi Uniti	1
AF - Afghanistan, Repubblica islamica di	1
AL - Albania	1
AU - Australia	1
AZ - Azerbaigian	1
BA - Bosnia-Erzegovina	1
BB - Barbados	1
BO - Bolivia	1
CG - Congo	1
CU - Cuba	1
CZ - Repubblica Ceca	1
DK - Danimarca	1
EG - Egitto	1
GE - Georgia	1
IE - Irlanda	1
LB - Libano	1
LV - Lettonia	1
NC - Nuova Caledonia	1
NI - Nicaragua	1
NP - Nepal	1
OM - Oman	1
PH - Filippine	1
PS - Palestinian Territory	1
RO - Romania	1
SI - Slovenia	1
SK - Slovacchia (Repubblica Slovacca)	1
SN - Senegal	1
SV - El Salvador	1
TH - Thailandia	1
TN - Tunisia	1
TT - Trinidad e Tobago	1
TW - Taiwan	1
ZA - Sudafrica	1
Totale	2.910

Nome	#
[18F]-florbetaben PET/CT is sensitive for cardiac AL amyloidosis	335
Wild-type transthyretin cardiac amyloidosis is not rare in elderly subjects: the CATCH screening study	283
Estimated total amyloid burden from 18F-florbetaben positron emission tomography predicts all-cause mortality in light-chain cardiac amyloidosis	255
Role of Imaging in Cardiomyopathies	253
Cardiac amyloidosis characterization by kinetic model fitting on [18F]florbetaben PET images	247
The Role of Scintigraphy with Bone Radiotracers in Cardiac Amyloidosis	233
Tissue Characterization in Cardiac Amyloidosis	226
Positron emission tomography in cardiac amyloidosis: current evidence and future directions	223
PET and Cardiac Amyloidosis	217
Estimated total amyloid burden from 18F-florbetaben positron emission tomography predicts all-cause mortality in light-chain cardiac amyloidosis	214
Automated Neural Architecture Search for Cardiac Amyloidosis Classification from [18F]-Florbetaben PET Images	199
Diagnosis and Prognostication With PET Imaging: The (Next) Future in Light Chain Amyloidosis	185
Diagnosis and Prognostication With PET Imaging: The (Next) Future in Light Chain Amyloidosis	57
Totale	2.927

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2022/2023	12	0	0	0	0	5	0	0	3	2	2	0	0
2023/2024	77	3	0	13	18	4	7	11	1	0	1	3	16
2024/2025	484	8	11	27	6	23	21	59	81	37	17	78	116
2025/2026	2.085	142	288	212	303	196	153	152	106	149	132	157	95
2026/2027	269	48	56	115	50	0	0	0	0	0	0	0	0
Totale													2.927